Advertisement

Magenkarzinom

  • H. Wilke
  • M. Stahl

Zusammenfassung

95% aller Magenkarzinome sind Adenokarzinome, wobei folgende Subtypen unterschieden werden: papillärer Typ, tubulärer Typ, muzinöser Typ, Siegelringzellkarzinom. Selten sind adenosquamöse Karzinome (4%) und Plattenepithelkarzinome, undifferenzierte und unklassifizierte Karzinome.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Moller JO, Estève J, Moller H et al. (1990) Cancer in the European Community and its Member States. Eur J Cancer 11 /12: 1167–1256Google Scholar
  2. 2.
    Gentsch HH (1986) Maligne Tumoren des Magens. In: Gall FP, Hermanek P, Tonak J (eds) Chirurgische Onkologie. Springer, Berlin Heidelberg New York London Paris Tokyo, pp 347–400CrossRefGoogle Scholar
  3. 3.
    Meyer HJ, Jähne J, Wilke H et al. (1991) Surgical Treatment of Gastric Cancer: Retrospective Survey of 1704 Operated Cases With Special Reference to Total Gastrectomy as the Operation of Choice. Sem Surg Oncol 17: 356–364CrossRefGoogle Scholar
  4. 4.
    Caudry M (1992) Gastric Cancer: Radiotherapy and Approaches to Locally Unresectable or Recurrent Disease. Lippincott Company, Philadelpha, pp 181–187Google Scholar
  5. 5.
    Preusser P, Achterrath W, Wilke H et al. (1988) Chemotherapy of Gastric Cancer. Cancer Treat Rev 15: 257–277PubMedCrossRefGoogle Scholar
  6. 6.
    Wilke H, Preusser P, Achterrath W et al. (1993) Chemotherapy of Gastric Cancer. Acta Chirurgica Austriaca (in press)Google Scholar
  7. 7.
    Wils JA, Klein HO, Wagener DJT et al. (1991) Sequential High-Dose Methotrexate and Fluorouracil Combined with Doxorubicin — A Step Ahead in the Treatment of Advanced Gastric Cancer: A Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol 9: 827–831Google Scholar
  8. 8.
    Wilke H, Preusser P, Fink U et al. (1989) Preoperative Chemotherapy in Locally Advanced and Nonresectable gastric Cancer: A Phase II Study With Etoposide, Doxorubicin, and Cisplatin. J Clin Oncol 7: 1318–1326Google Scholar
  9. 9.
    Mahjoubi M, Rougier P, Oliviera J et al. (1990) Phase II Trial of Combined 5-FU + CDDP in gastric cancer. J Cancer Res Clin Oncol (Suppl, Paert 1) 116: 677 (abstr)Google Scholar
  10. 10.
    Klein HO, Wickramanayak PD, Farrkh GR (1986) 5-Fluorouracil (5-FU), Adriamycin (ADM), and Methotrexate (MTX) — A Combination Protocol ( FAMTX) for Treatment of Metastasized Stomach Cancer. Proc Am Soc Clin Oncol 84: 86Google Scholar
  11. 11.
    Wilke H, Preusser P, Fink U et al. (1990) High Dose Folinic Acid/Etoposide/5-Fluorouracil in Advanced Gastric Cancer — A Phase lI Study in Elderly Patients or Patients With Cardiac Risk. Invest New Drugs 8: 65–70PubMedCrossRefGoogle Scholar
  12. 12.
    Preusser P, Wilke H, Achterrath W et al. (1989) Phase Il Study With Etoposide, Doxorubicin, and Cisplatin in Advanced and Measurable Gastric Cancer. J Clin Oncol 9: 1310–1317Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • H. Wilke
  • M. Stahl

There are no affiliations available

Personalised recommendations